The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Workforce
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Gut Microbiota Directly Affects Inflammatory Arthritis

Gut Microbiota Directly Affects Inflammatory Arthritis

May 8, 2018 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Despite extensive genetic studies of patients with rheumatoid arthritis (RA), researchers cannot successfully predict which individuals will ultimately develop disease. This knowledge gap has led many to assume that environmental triggers must be important for RA pathogenesis. Others have even proposed that the gut microbiota can provide such a trigger. This hypothesis is based on data indicating that gastrointestinal microbial imbalance can contribute to the development of autoimmune diseases. More specifically, not only do mice with clinical arthritis exhibit dysbiosis, but so, too, do patients with symptomatic RA.

You Might Also Like
  • Fungal Microbiota Dysbiosis Seen in Inflammatory Bowel Disease
  • Dysbiosis of Gut, But Not Ocular Microbiome, Associated with Sjögren’s Syndrome
  • Research Suggests Th17 Cells Have Microbiota-Dependent Role in RA
Also By This Author
  • Periodontitis May Provide Insight into RA

Intestinal Dysbiosis Triggers Mucosal Immune Response
New research in mice suggests intestinal dysbiosis triggers a mucosal immune response that stimulates the T and B cells critical for the development of inflammatory arthritis. Widian K. Jubiar, MS, MD, postdoctoral fellow at the University of Colorado School of Medicine in Aurora, Colo., and colleagues used the murine collagen-induced arthritis (CIA) model to examine how both the microbiota and mucosal immune response change over time. They published their results March 13 in Arthritis & Rheumatology.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“From our study and the ongoing studies of many others in rheumatology and other fields, we know that there is an important role of the microbiome in educating our immune system,” writes co-author Kristine Kuhn, MD, PhD, assistant professor of medicine at the University of Colorado School of Medicine in an email interview with The Rheumatologist. “We believe that continued work in these areas will reveal unique pathways in how gut bacteria influence the development of many different autoimmune diseases.”

The Study
Dr. Jubiar and colleagues used the CIA model that induces arthritis in genetically susceptible DBA/1J mice via immunization with bovine collagen type II (CII) emulsified in complete Freund’s adjuvant (CFA). The mice are immunized on Day 0 and Day 21 and develop arthritis between Days 23 and 24. Researchers measured disease severity every two days by determining a mean clinical score from the animal’s four paws with 0=normal, 1=erythema, 2=swelling and 3=ankylosis. Not all of the mice treated in this way develop arthritis. Previous studies have shown the mice that developed disease had intestinal dysbiosis relative to those that were immunized and did not develop observable joint swelling.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In the current study, the investigators hypothesized the microbiota could modulate immune responses that lead to autoimmune arthritis. If true, then it should be possible to identify the critical point at which dysbiosis-modulated disease activity occurs. The team sought to identify this time point.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Rheumatoid Arthritis Tagged With: Arthritis & Rheumatology, environment, environmental factor, gut microbiome, gut microbiota, Inflammatory arthritis, Rheumatoid Arthritis (RA)

You Might Also Like:
  • Fungal Microbiota Dysbiosis Seen in Inflammatory Bowel Disease
  • Dysbiosis of Gut, But Not Ocular Microbiome, Associated with Sjögren’s Syndrome
  • Research Suggests Th17 Cells Have Microbiota-Dependent Role in RA
  • The Microbiome’s Role in Inflammatory Arthritis

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.